An antibiotic developed some 80 years ago before being abandoned and forgotten could again offer exciting new solutions, this ...

Trial reaches dosing milestone, with 20 of the 30 total patients dosedAll patients dosed met the primary endpoints of the study, either a cure or ...

Three of these six pathogens are antibiotic-resistant Gram-negative ... However, there are no drugs being developed against class C ESBL-producing Gram-negative bacteria. Here, we draw attention ...

Recently, a new antimicrobial class, the glycylcyclines, has been found to treat resistant gram-positive and -negative infections ... for patients allergic to penicillin. This article reviews ...

Readers familiar with my prior research on Acurx Pharmaceuticals (NASDAQ:ACXP) know that I have a generally negative ... class of antibiotics. They are focusing on infections caused by Gram ...

First randomized placebo-controlled trial in NTM abscessusSymptom-based endpoints showed favorable improvement in frequency and severity of the most common symptomsMicrobiologic endpoints showed ...

Gram-positive and gram-negative bacteria have different cell wall structures ... a resurgence of interest in this historically significant, yet long-forgotten class of antibiotics." ...

For example, mobile colistin resistance genes (mcr-1 to mcr-10) and their variants have been identified in gram-negative bacteria which pose a ... potentiating the killing effect of carbapenems on KPC ...

Study DUS-AUBD-01 opens patient enrollment PRINCETON, N.J., Nov. 14, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...

Good afternoon, and welcome to the Beyond Meat Third Quarter 2024 Conference Call. All participants are in listen-only mode. [Operator Instructions] After today's presentation, there will be an ...

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated ... caused by susceptible Gram-negative organisms. Venatorx Pharmaceuticals and partner Melinta ...